Precision BioSciences
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Precision BioSciences's past years’ income statements indicate that its last revenue has increased compared to the previous period by 94% to $48,727,000. The net income raised on -$61,319,000 and profit margin reached -126%. Total operating expenses were $92,463,000.

Profit Margin

Precision BioSciences, Inc. (NASDAQ:DTIL): Profit margin
2017 6.48M -21.10M -325.45%
2018 10.88M -46.03M -423.02%
2019 22.23M -83.30M -374.59%
2020 24.28M -109.00M -448.86%
2021 115.52M -30.91M -26.76%
2022 25.09M -122.90M -489.71%
2023 48.72M -61.31M -125.84%

DTIL Income Statement (2017 – 2023)

2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue
48.72M25.09M115.52M24.28M22.23M10.88M6.48M
Cost of revenue
8.25M9.00M00000
Gross profit
40.47M16.09M115.52M24.28M22.23M10.88M6.48M
Operating exp.
Research and development
53.37M83.93M115.23M98.06M82.41M45.12M20.32M
Selling and marketing
0000000
Total operating expenses
92.46M125.46M154.93M134.11M109.44M58.79M28.34M
Operating income
-43.73M-100.36M-39.40M-109.82M-87.20M-47.91M-21.97M
Other income (expenses), net
1.20M-11.27M8.8M822K-5.67M1.87M872K
Income before tax
-42.52M-111.63M-30.60M-109.00M-92.87M-46.03M-21.10M
Income tax expense
011.27M316K10.42M-9.57M1.87M-754K
Net income
-61.31M-122.90M-30.91M-109.00M-83.30M-46.03M-21.10M
Earnings per share
Basic EPS
-15.96-41.95-15.8-62.85-59.5-28.17-18.81
Diluted EPS
-15.96-41.95-15.8-62.85-59.5-28.17-18.81
Data sourceData sourceData sourceData sourceData source